lamivudine and zidovudine
lamivudine and zidovudine is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including LAMIVUDINE AND ZIDOVUDINE, COMBIVIR. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- lamivudine and zidovudine
- Brand Names
- LAMIVUDINE AND ZIDOVUDINE, COMBIVIR
- Application Number
- ANDA203259
- Sponsor
- XLCare Pharmaceuticals, Inc
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- LAMIVUDINE, ZIDOVUDINE
Indications and Usage
1 INDICATIONS AND USAGE Lamivudine and zidovudine tablets a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogue reverse transcriptase inibitors, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.